Condition
Peritoneal Metastases From Gastric Cancer clinical trials and research
Research outlook What's coming for Stomach cancer: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 3 Peritoneal Metastases From Gastric Cancer clinical trials that are recruiting, at sites in 3 countries (most in China (1), Netherlands (1), Ukraine (1)). By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3Clinical trials
- 3Countries
Newest Peritoneal Metastases From Gastric Cancer clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| LM-302 plus oral S-1 and intraperitoneal paclitaxel, with or without cadonilimab, for Claudin 18.2–positive advanced stomach or GEJ cancer with peritoneal spread | Phase 2 | Shanghai, Huangpu District | Recruiting | Apr 29, 2026 |
| HIPEC during curative gastrectomy for advanced or low‑volume metastatic gastric cancer | — | Kyiv | Recruiting | Jan 2, 2026 |
| Combination intraperitoneal and systemic therapy for gastric cancer with peritoneal metastases | Phase 2 | Amsterdam and 2 other locations | Recruiting | Aug 21, 2025 |
All recruiting trials (3)
-
LM-302 plus oral S-1 and intraperitoneal paclitaxel, with or without cadonilimab, for Claudin 18.2–positive advanced stomach or GEJ cancer with peritoneal spread
This trial tests whether adding cadonilimab to LM-302, oral S-1, and intraperitoneal paclitaxel helps people with Claudin 18.2–positive gastric or gastroesophageal junction cancer that has spread to the peritoneum.
-
HIPEC during curative gastrectomy for advanced or low‑volume metastatic gastric cancer
This tests whether adding a single heated dose of chemotherapy inside the abdomen (HIPEC) during curative gastrectomy helps people with T4 tumors or low‑volume peritoneal gastric cancer.
-
Combination intraperitoneal and systemic therapy for gastric cancer with peritoneal metastases
This phase 2 trial tests a new combination treatment for adults with gastric cancer that has spread to the lining of the abdomen, using intraperitoneal irinotecan with standard systemic therapy and biomarker-guided addition of nivolumab or trastuzumab when appropriate.
Related topics
Quick answers
How many Peritoneal Metastases From Gastric Cancer clinical trials are recruiting right now?
3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (1 trial), Netherlands (1 trial), Ukraine (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.